Clearwater Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $302K | Hold |
2,384
| – | – | 0.03% | 137 |
|
|
2025
Q1 | $305K | Sell |
2,384
-30
| -1% | -$3.84K | 0.03% | 139 |
|
|
2024
Q4 | $319K | Hold |
2,414
| – | – | 0.03% | 137 |
|
|
2024
Q3 | $351K | Buy |
2,414
+70
| +3% | +$10.2K | 0.03% | 131 |
|
|
2024
Q2 | $322K | Hold |
2,344
| – | – | 0.03% | 124 |
|
|
2024
Q1 | $322K | Hold |
2,344
| – | – | 0.03% | 125 |
|
|
2023
Q4 | $318K | Hold |
2,344
| – | – | 0.04% | 120 |
|
|
2023
Q3 | $287K | Hold |
2,344
| – | – | 0.04% | 113 |
|
|
2023
Q2 | $298K | Hold |
2,344
| – | – | 0.04% | 117 |
|
|
2023
Q1 | $303K | Hold |
2,344
| – | – | 0.04% | 114 |
|
|
2022
Q4 | $308K | Hold |
2,344
| – | – | 0.04% | 119 |
|
|
2022
Q3 | $274K | Hold |
2,344
| – | – | 0.04% | 126 |
|
|
2022
Q2 | $276K | Sell |
2,344
-50
| -2% | -$5.89K | 0.04% | 119 |
|
|
2022
Q1 | $312K | Hold |
2,394
| – | – | 0.04% | 129 |
|
|
2021
Q4 | $365K | Hold |
2,394
| – | – | 0.04% | 122 |
|
|
2021
Q3 | $387K | Sell |
2,394
-20
| -0.8% | -$3.23K | 0.04% | 113 |
|
|
2021
Q2 | $395K | Sell |
2,414
-656
| -21% | -$107K | 0.05% | 118 |
|
|
2021
Q1 | $462K | Sell |
3,070
-348
| -10% | -$52.4K | 0.06% | 108 |
|
|
2020
Q4 | $518K | Hold |
3,418
| – | – | 0.07% | 98 |
|
|
2020
Q3 | $463K | Sell |
3,418
-34,407
| -91% | -$4.66M | 0.07% | 98 |
|
|
2020
Q2 | $5.17M | Buy |
37,825
+7,625
| +25% | +$1.04M | 0.86% | 28 |
|
|
2020
Q1 | $3.25M | Buy |
30,200
+9,867
| +49% | +$1.06M | 0.7% | 28 |
|
|
2019
Q4 | $2.45M | Sell |
20,333
-155
| -0.8% | -$18.7K | 0.41% | 50 |
|
|
2019
Q3 | $2.04M | Buy |
20,488
+2,638
| +15% | +$263K | 0.36% | 67 |
|
|
2019
Q2 | $1.95M | Buy |
17,850
+725
| +4% | +$79.1K | 0.35% | 73 |
|
|
2019
Q1 | $1.92M | Buy |
17,125
+2,579
| +18% | +$288K | 0.36% | 78 |
|
|
2018
Q4 | $1.4M | Buy |
14,546
+2,610
| +22% | +$252K | 0.31% | 99 |
|
|
2018
Q3 | $1.46M | Buy |
11,936
+338
| +3% | +$41.2K | 0.28% | 88 |
|
|
2018
Q2 | $1.27M | Buy |
11,598
+72
| +0.6% | +$7.91K | 0.26% | 88 |
|
|
2018
Q1 | $1.23M | Buy |
11,526
+7,344
| +176% | +$784K | 0.25% | 91 |
|
|
2017
Q4 | $450K | Buy |
4,182
+69
| +2% | +$7.43K | 0.1% | 126 |
|
|
2017
Q3 | $465K | Buy |
4,113
+36
| +0.9% | +$4.07K | 0.11% | 122 |
|
|
2017
Q2 | $421K | Buy |
4,077
+1,020
| +33% | +$105K | 0.11% | 120 |
|
|
2017
Q1 | $293K | Buy |
3,057
+510
| +20% | +$48.9K | 0.08% | 136 |
|
|
2016
Q4 | $229K | Sell |
2,547
-114
| -4% | -$10.3K | 0.08% | 135 |
|
|
2016
Q3 | $256K | Sell |
2,661
-1,431
| -35% | -$138K | 0.09% | 125 |
|
|
2016
Q2 | $363K | Buy |
+4,092
| New | +$363K | 0.13% | 103 |
|